|
Market Closed -
Other stock markets
|
After hours 17:52:35 | |||
| 693.20 EUR | -0.14% |
|
693.30 | +0.01% |
| 05-12 | Argenx SE Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 10:40 AM | |
| 05-12 | ARGENX : Bernstein reiterates its Buy rating | ZD |
Company Valuation: argenx SE
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 16,291 | 19,269 | 20,293 | 36,221 | 43,868 | 43,171 | - | - |
| Change | - | 18.28% | 5.32% | 78.48% | 21.11% | -1.59% | - | - |
| Enterprise Value (EV) 1 | 14,186 | 18,515 | 17,352 | 32,974 | 40,948 | 38,606 | 36,560 | 34,779 |
| Change | - | 30.52% | -6.28% | 90.03% | 24.18% | -5.72% | -5.3% | -4.87% |
| P/E ratio | -43.8x | -28.3x | -72.1x | 48.9x | 43.2x | 29.7x | 22.5x | 17.5x |
| PBR | 7.1x | - | 5.39x | 7.4x | - | 5.62x | 4.37x | 3.51x |
| PEG | - | -0.4x | 1.2x | -0x | 1.2x | 0.7x | 0.7x | 0.6x |
| Capitalization / Revenue | 33.5x | 45.9x | 17.3x | 16.9x | 12.2x | 8.5x | 6.98x | 5.93x |
| EV / Revenue | 29.2x | 44.1x | 14.8x | 15.4x | 11.4x | 7.6x | 5.92x | 4.78x |
| EV / EBITDA | -45.7x | -31.9x | -59.8x | -8,314x | 44.6x | 22.8x | 16.8x | 12.8x |
| EV / EBIT | -45.1x | -27.3x | -44.2x | -1,600x | 45.9x | 23.6x | 16.7x | 12.5x |
| EV / FCF | -25.7x | -22.8x | -40.4x | -227x | 84.2x | 17.8x | 14.1x | 12.7x |
| FCF Yield | -3.9% | -4.39% | -2.47% | -0.44% | 1.19% | 5.63% | 7.11% | 7.85% |
| Dividend per Share 2 | - | - | - | - | - | 0.4248 | 0.8495 | 0.8485 |
| Rate of return | - | - | - | - | - | 0.06% | 0.12% | 0.12% |
| EPS 2 | -7.203 | -12.31 | -4.763 | 12.28 | 16.58 | 23.37 | 30.84 | 39.73 |
| Distribution rate | - | - | - | - | - | 1.82% | 2.75% | 2.14% |
| Net sales 1 | 486.3 | 419.9 | 1,171 | 2,143 | 3,599 | 5,078 | 6,181 | 7,282 |
| EBITDA 1 | -310.4 | -580.3 | -290.2 | -3.966 | 917.2 | 1,694 | 2,172 | 2,718 |
| EBIT 1 | -314.4 | -679.3 | -392.3 | -20.61 | 892.8 | 1,639 | 2,184 | 2,791 |
| Net income 1 | -368.1 | -669.1 | -272.3 | 792.7 | 1,095 | 1,513 | 2,067 | 2,508 |
| Net Debt 1 | -2,105 | -754.3 | -2,942 | -3,247 | -2,920 | -4,565 | -6,611 | -8,392 |
| Reference price 2 | 315.30 | 348.30 | 343.50 | 600.00 | 716.80 | 694.20 | 694.20 | 694.20 |
| Nbr of stocks (in thousands) | 51,668 | 55,324 | 59,079 | 60,368 | 61,200 | 62,188 | - | - |
| Announcement Date | 03/03/22 | 02/03/23 | 29/02/24 | 27/02/25 | 26/02/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 29.71x | 7.6x | 22.79x | 0.06% | 50.39B | |
| 17.05x | 5.19x | 11.35x | 1.74% | 46.03B | |
| -43.01x | 14.38x | -39.04x | -.--% | 25.06B | |
| -18.29x | 3.39x | -6.18x | -.--% | 23.26B | |
| 21.35x | 4.22x | 10.94x | -.--% | 17.24B | |
| 22.89x | 4.47x | 14.74x | -.--% | 16.15B | |
| 769.56x | 18.13x | 98.99x | -.--% | 14.56B | |
| -15.7x | 4028.17x | -19.97x | -.--% | 14.08B | |
| -438.46x | 31.36x | -1963.9x | -.--% | 12.94B | |
| 16.18x | 4.65x | 10.9x | -.--% | 12.84B | |
| Average | 36.13x | 412.16x | -185.94x | 0.18% | 23.26B | |
| Weighted average by Cap. | 30.24x | 252.19x | -99.53x | 0.36% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- ARGX Stock
- Valuation argenx SE
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition